$GOSS
Gossamer Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
GOSS chart
What traders are saying about $GOSS
Latest postsGossamer Bio, Inc. news
- GOSS Maintained by Chardan Capital -- Rating Remains Buy
GuruFocus ·
- Gossamer Bio(GOSS) Stock Options Chain | Quotes & News
Moomoo ·
- Chardan reiterates Gossamer Bio stock rating on PAH drug outlook By Investing.com
Investing.com Australia ·
- Gossamer Bio, Inc. Estimates – NASDAQ:GOSS
TradingView ·
- Gossamer Bio (GOSS) Stock Sees Fair Value Lift As Analysts Weigh Seralutinib Risks
Yahoo Finance ·
- Adobe downgraded, VF Corp. upgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Gossamer Bio (GOSS) Stock Draws Fresh Price Target Split Before Seralutinib NDA
Yahoo Finance ·
- Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension
Yahoo Finance ·
- Gossamer Bio Appoints Greg Ciongoli to Board of Directors
Yahoo Finance ·
- Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
Yahoo Finance ·
- Gossamer Bio Announces 1-for-80 Reverse Stock Split
Yahoo Finance ·
- Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
Yahoo Finance ·
Gossamer Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $48.5M | $114.7M | $0 | $0 |
| Net income | -$170.4M | -$56.5M | -$179.8M | -$229.4M |
| Diluted EPS | $-0.75 | $-0.25 | $-1.18 | $-2.71 |
| Total assets (year end) | $172.2M | $315.3M | $311.9M | $272.4M |
| Cash and equivalents (year end) | $37.7M | $46.1M | $32.1M | $112.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gossamer Bio, Inc.
- Ticker
- GOSS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1728117
Frequently asked questions
What exchange is Gossamer Bio, Inc. listed on?
Gossamer Bio, Inc. trades on the Nasdaq under the ticker symbol GOSS.
What industry is Gossamer Bio, Inc. in?
Gossamer Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Gossamer Bio, Inc. headquartered?
Gossamer Bio, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Gossamer Bio, Inc.'s fiscal year end?
Gossamer Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Gossamer Bio, Inc. report?
Gossamer Bio, Inc. reported $48.5M in revenue for calendar year 2025, according to its SEC filings.